Please select a video from the list below.
PAH-Related Morbidity Is Prognostic for Mortality
In this important breaking trial analysis publication, Dr. Vallerie McLaughlin discusses the use of landmark analysis procedures on morbidity and mortality endpoints from 2 large Phase 3 trials, SERAPHIN and GRIPHON. The publication, published in JACC shows how a clinical morbidity event influences risk of death in patients treated with or without macitentan or selexipag. Dr. McLaughlin discusses the importance of using these findings to adjust patients' therapeutic management.
Recent Video
Most Viewed
Specialties :                    Search :
RESPITE Study Results
RESPITE Study Results Views - 919
ICU Management of PH
ICU Management of PH Views - 142